ASPC 2020 Virtual Summit on CVD Prevention

Videos

NIH Scientific Approach to Inclusive Excellence: Why Diversity Matters? How to Create Inclusive Scientific Environments Where Diverse Talent Thrives?

By ASPC 2020 Virtual Summit on CVD Prevention FEATURING Hannah A. Valantine

11 views

March 17, 2021

Comments 0

Videos

Integrating Imaging & Advanced Blood Testing for CVD Prevention/Mana…

ASPC 2020 Virtual Summit on CVD Prevention

A. Agatston

484 views

Implementation of FIND FH Into Clinical Care at Penn Medicine: Can M…

ASPC 2020 Virtual Summit on CVD Prevention

S. Sheth

10 views

Lessons Learned from the ISCHEMIA Trial: How to Diagnose/Manage CAD …

ASPC 2020 Virtual Summit on CVD Prevention

D. Maron

398 views

Managing Patients With Stable CAD: When to Consider the Cath Lab? Wh…

ASPC 2020 Virtual Summit on CVD Prevention

D. Maron

1.3K views

ASPC Expert Discussion on Biologics Usage for CV Risk Reduction, Eff…

ASPC 2020 Virtual Summit on CVD Prevention

C. Ballantyne, A. Marie Navar, D. Maron, K. Ferdinand, P. Ridker

39 views

Continuity of Care for Patients With/At High Risk for CVD During COV…

ASPC 2020 Virtual Summit on CVD Prevention

A. Khera

91 views

Management of HF With Preserved Ejection Fraction: How Can We Preven…

ASPC 2020 Virtual Summit on CVD Prevention

D. Schocken

136 views

How Can We Prevent the Majority of CV Events? What Are the Milion He…

ASPC 2020 Virtual Summit on CVD Prevention

L. Sperling

352 views

NIH Scientific Approach to Inclusive Excellence: Why Diversity Matte…

ASPC 2020 Virtual Summit on CVD Prevention

H. A. Valantine

11 views

ASPC CVD Prevention Panel Discussion: How Can We Educate Our Patient…

ASPC 2020 Virtual Summit on CVD Prevention

L. Shaw, N. Wenger, V. Taqueti, R. Bullock-Palmer, E. Michos, M. Gulati, P. Taub

21 views

Expert Discussion on Transdermal Hormone Replacement Therapy & How t…

ASPC 2020 Virtual Summit on CVD Prevention

L. Shaw, N. Wenger, V. Taqueti, R. Bullock-Palmer, E. Michos, M. Gulati, P. Taub

19 views

Disparities in the Use of Preventive Medications and Risk Factor Con…

ASPC 2020 Virtual Summit on CVD Prevention

K. Vu

11 views

100 Years from C-Reactive Protein to Anti-Inflammatory Therapy for A…

ASPC 2020 Virtual Summit on CVD Prevention

P. Ridker

63 views

Apolipoprotein B & CVD Risk: How Can We Improve CVD Prevention With …

ASPC 2020 Virtual Summit on CVD Prevention

A. Sniderman

375 views

Adverse Pregnancy Outcomes & CVD Risk: What Are the Risks and How to…

ASPC 2020 Virtual Summit on CVD Prevention

R. Bullock-Palmer

7 views

FH Visual Aids in Patient Education Research Highlights: Can Distrib…

ASPC 2020 Virtual Summit on CVD Prevention

D. M. Harmon

18 views

HF With Preserved Ejection Fraction: How to Distinguish HFrEF & HFpE…

ASPC 2020 Virtual Summit on CVD Prevention

D. Schocken

22 views

Diagnosis/Management of CMD: How to Use Novel Imaging Tools to Under…

ASPC 2020 Virtual Summit on CVD Prevention

V. Taqueti

18 views

Atherosclerosis & MicroRNAs: How MicroRNAs Impacts Risk for Atheroge…

ASPC 2020 Virtual Summit on CVD Prevention

P. Toth

100 views

Primary Prevention by CAC vs. CTA: Which One Is Better and Why? - SC…

ASPC 2020 Virtual Summit on CVD Prevention

J. Min, K. Nasir

41 views

Jackson Heart Study Overview: Racial Disparity Trends, Risk Assessme…

ASPC 2020 Virtual Summit on CVD Prevention

H. Taylor

15 views

ASPC Panel Discussion on CV Risk Prevention With Nutrition, Hyperten…

ASPC 2020 Virtual Summit on CVD Prevention

K. Ferdinand, D. Maron, L. Sperling, I. Pina, H. Taylor

19 views

Discussion on CTA/CAC for Primary Prevention, Genetic Testing, LDL M…

ASPC 2020 Virtual Summit on CVD Prevention

R. Blankstein, S. Virani, A. Agatston, J. Min, S. Sheth, K. Nasir, A. Khera

27 views

New Insights Into Assessing Risk for Hispanic Patients: Why it Is Im…

ASPC 2020 Virtual Summit on CVD Prevention

I. Pina

11 views

Menopause and Its Impact on Women's CVD Health: How to Assess Risk F…

ASPC 2020 Virtual Summit on CVD Prevention

E. Michos

485 views

Genetic Testing in Preventive Cardiology: Are Those With FH Mutation…

ASPC 2020 Virtual Summit on CVD Prevention

A. Khera

358 views

Statin Usage in Athletes: Is There Increased Muscle Injury With Stat…

ASPC 2020 Virtual Summit on CVD Prevention

P. D. Thompson

22 views

Sex Differences in Atherosclerosis: Is There a Sex Specific Phenotyp…

ASPC 2020 Virtual Summit on CVD Prevention

L. Shaw

29 views

Polypill for CVD Prevention: When Is Polypharmacy Appropriate? Can R…

ASPC 2020 Virtual Summit on CVD Prevention

K. Ferdinand

164 views

CVD Prevention for Women: What Are the Unique/Predominant Risk Facto…

ASPC 2020 Virtual Summit on CVD Prevention

N. Wenger

17 views

Login

Login

Join VuMedi